VAISHALI PHARMA
Back to Balance Sheet
|
VAISHALI PHARMA Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | - | - | - | - |
What is the latest Contingent Liabilities ratio of VAISHALI PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
| Mar2020 | - |
How is Contingent Liabilities of VAISHALI PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | 0 | |
| Mar2020 | - | - | |
Compare Contingent Liabilities of peers of VAISHALI PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VAISHALI PHARMA | ₹128.4 Cr | -2.3% | -13.5% | -46.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹404,468.0 Cr | -1.1% | 1.9% | -8.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,810.0 Cr | 3.5% | 18.2% | 15.4% | Stock Analytics | |
| CIPLA | ₹121,170.0 Cr | -2.6% | -0.9% | -3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,300.0 Cr | -1.3% | 0.8% | 11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,575.0 Cr | 0.2% | -3.5% | -5.8% | Stock Analytics | |
VAISHALI PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | -2.3% |
-13.5% |
-46.2% |
| SENSEX | -2% |
2.6% |
4.2% |
You may also like the below Video Courses